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ORIGINAL INVESTIGATION
Utility of Scintigraphic Methods in Patients 
With Fever of Unknown Origin
Elisabeth M. H. A. clc Kleijn, MD; Wim J. G. Oyen, MD; Roland A. M . J. Claessens, MD, PhD; 
Frans H. M. Corstcns, MD; Jos W. M. van der Meer, MD
Background: We assessed die utility of scintigraphy with 
indium I l l - l a b e le d  polyclonal hum an lgG scintigra­
phy in patients with fever of unknow n origin that ful­
filled the criteria of temperature of 38.3°C or more for 
ai least 3 weeks and no diagnosis during 1 week of hos­
pital admission. We compared the utility of this tech­
nique with results of scintigraphic techniques reported 
in die literature.
Methods: Data for all patients seen at our university hos­
pital in whom m In-lgG scanning was performed were 
analyzed and checked for the criteria for fever of u n ­
known origin. The literature on the utility of scinti- 
g ip hie techniques in patients with fever of unknow n 
origin was reviewed.
Results: We stud ied  24 pa tien ts  w ith  fever of u n ­
known origin. In 13 patients, focal m ln-lgG accum ula­
tion was observed. In nine (38%) of those, the positive 
In-lgG scintigram led to the final diagnosis; in the other 
lour patients (17%), the scintigraphic findings were not
helpful. In the 11 patients with negative m ln-IgG scans, 
extensive diagnostic workup produced no infection as 
the final diagnosis in nine patients (38%), one had an ab­
scess in a renal cyst that was detected several months later, 
and in the other the cause of fever was an infected intra­
venous line. The overall sensitivity and specificity of 
m In-IgG scintigraphy were 81% and 69%, respectively. 
The positive predictive value was 69% and the negative 
predictive value was 82%.
Conclusions: Our results show that 111 In-lgG scintig­
raphy significantly contributed to the diagnostic p ro­
cess in patients with fever of unknow n origin. A posi­
tive scan increased the likelihood of finding the cause of 
the fever, and a negative scan ruled out an inflammatory 
com ponent with a high degree of certainty. These data 
compare favorably with data in the literature concern­
ing other radiopharmaceuticals; a larger prospective evalu­
ation of this technique is indicated.
(Arch Intern Med. 1995;155:1989-1994)
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EVER OF u n k n o w n  orig in  
(FUO) has been defined by 
Petersdorf and Beeson1 as a 
febrile illness of more than
3 w eeks’ d u ra tio n , d o c u ­
mented temperature higher than 38.3°C 
on at least three occasions, and uncertain 
d iag n o s is  a fte r  1 w eek  of d iag n o s tic  
workup in the hospital. Currently, a va­
riety of diagnostic imaging procedures, in­
c lu d in g  rad io g rap h y , m agnetic  re so ­
nance im aging, u ltra so n o g rap h y , and 
scintigraphy, are potentially useful in pa­
tients with FUO.
S cin tig raph ic  im aging, in c lu d in g  
gallium 67,2'l) white blood cells (WBCs) 
labeled w ith  in d iu m  In 1 1 1 , 10*12 and, 
m o s t re c e n t ly ,  te c h n e t iu m  T c 9 9 m -  
labeled BW250/183, an antigranulocyte 
m o n o c lo n a l an tib o d y  of m u rin e  o r i­
g in , 13 has been applied in patients with 
FUO to d e te c t  in fe c t io u s  an d  o th e r  
inflammatory foci. A positive scintigram
enhances the likelihood of establishing 
a final diagnosis .8
A relatively new and potentially use­
ful technique for this ind ication  is in ­
dium 111-labeled polyclonal hum an IgG 
scintigraphy. Recently, the utility o f 11’In- 
lgG scintigraphy in the evaluation of vari­
ous types of focal inflammation and in­
fection has been studied. Reports have been 
published in the literature on bone and 
joint infections14,1 ’ and abdom inal, 10 pu l­
monary ,17 and vascular18 lesions. This tech­
nique is also applicable in granulocytope­
n ic  p a t i e n t s . 10 S ince  11 ' I n - lg G  is a 
convenient and safe radiopharm aceuti­
cal, comparing favorably with other scin-
See Patients and Methods 
on next page
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PATIENTS AND METHODS
PATIENTS
Records of all patients who underw en t 11'In-lgG scintig­
raphy in our hospital were reviewed for F U O .1 Twenty- 
four patients (11 w om en and 13 men; mean age, 51 years; 
median, 52 years) fulfilled the criteria for FUO. From our 
studies of FUO carried out during the same period, we found 
th a t  4 5 % of the  p a t i e n t s  w ith  FU O  had  u n d e r g o n e  
11'In-lgG scintigraphy.
All patients underw ent full biochemical and appropri­
ate further investigations, including extensive negative mi­
crobiologic methods, which failed to establish a diagnosis 
within 1 week of admission. These investigations varied from 
patient to patient; no protocol was followed. The median fol­
low-up of these patients was 216 days (range, 2 to 1500 days).
The final diagnosis was made by the patients’ physi­
cians and checked by one of us (E.M.H.A.K.).
RADIOPHARMACEUTICAL
H um an nonspecific polyclonal IgG (Sandoglobulin, San­
doz AG, Nürnberg, Germany) was conjugated to diethyl- 
enetriamine pentaacetic bicyclic anhydride according to the 
m ethod described by Hnatowich ct alJ0 and labeled with
J
indium  111 ( indium  [ '" In ]  chloride, Mcdgenix Diagnos­
tics, F leurus, Belgium). Labeling efficiency was always 
greater than 95%. A dose of 1 to 2 mg of IgG labeled with 
75 MBq of ‘" In  was injected intravenously.
IMAGING PROCEDURES
Exclusion criteria for 11‘In-lgG scintigraphy were agam ­
maglobulinemia, selective IgA deficiency, and a history of
severe adverse reactions after in travenous or in tram uscu­
lar adm in is tra tion  of hum an  IgG. Pregnant or lactating 
w om en were also excluded from this study.
Scintigraphic images were obtained with a gamma cam­
era (Siemens Orbitcr, Siemens Inc, Hoffman Estates, 111) 
connected to an image processor (Scintiview, Siemens Inc). 
All images were collected in digital format in a 256X 256 
matrix. A m edium -energy parallel-hole collimator ( 173- 
keV peak, 15% symmetric window; 247-keV peak, 15% sym­
metric w indow ) was used.
The ' "In-lgG images were acquired 4 , 24 , and 48 hours 
after injection for a preset time of 5 , 7 .5 , and 10 m inutes, 
respectively. At least once, 24 hours  after injection, spot 
views of the total body  were ob ta ined . S ing le-pho ton- 
emission com puted  tom ographic  images were recorded 
w hen neccssary for more definite localization in three d i­
m ensions of areas with increased uptake.
All im ages  w ere  in te rp re te d  by th ree  o b se rv e rs ,  
“b l in d e d ” to the results of the verification procedures . 
D isa g re e m e n ts  w ere  reso lved  by c o n se n su s  o p in io n .  
Hypercmic noninflamed lesions may initially show some 
u p tak e  b u t  no fu r th e r  accu m u la t io n  of '" In - lg G  with 
t im e .2' These scans were in te rp re ted  as equivocal and 
no t p a th o lo g ic .  An ‘" In - lg G  scan  was in te rp re te d  as 
positive only if consistent, focally increasing accum ula­
tion could be noted  over time. An " 'In - lg G  scintigram  
was considered  “true positive” only w hen  this imaging 
procedure was considered helpful in diagnosis.
The results of the scintigraphic findings were veri­
fied by clinical, radiographic, and ultrasonographic m eth ­
ods and preferably by microbiologic methods.
STATISTICS
Differences between groups were analyzed by the Mann- 
W hitney  U test or S tudent’s L test, w hen  necessary.22
tigraphic techniques, we studied its diagnostic utility in 
patients with FUO.
RESULTS
In 13 (54%) of 24 patients, focal accumulation of activity 
increasing with time was observed. In nine patients (38%), 
scintigraphy was diagnostically helpful (Table 1); in eight 
of these, inflammatory or infectious foci were identified 
as the cause of the fever (Figure 1 and Figure 2 ). In four 
other patients (17%), a positive '"In-lgG scintigram did 
not lead to the final diagnosis (Table 1).
Table 1 also shows the data for the remaining 11 pa­
tients, in whom  a negative or equivocal " ‘In-lgG scinti­
gram was obtained. In six of those patients, extensive 
workup disclosed no diagnosis; follow-up from the start 
of fever varied from 224 to 929 days (median, 515 days). 
In two patients a malignant neoplasm most probably was 
the cause of fever, and one patient had positive blood cul­
tures with Salmonella enteritidis serotype paratyphi A. The 
two remaining patients had infections as the cause of the 
fever despite negative IgG scintigrams; one had an in­
fec ted  ren a l cyst, d ia g n o se d  3 m o n th s  a f te r  the  
negative ' "In-lgG scan, and the other had an infected cen­
tral venous catheter.
If we considered results o f 1 "In-lgG scintigraphy as 
true positive only when this imaging procedure led to 
the diagnosis, sensitivity was 82%, specificity was 69%, 
and positive and negative predictive value was 69% and 
82%, respectively.
Comparison of the erythrocyte sedimentation rate 
of patients with positive scans (m ean±SD , 80 .8±43.0  
m m /h ) w ith  th a t  of p a t ie n ts  w ith  n eg a tiv e  scans 
(m ean±SD, 70.5±47.5 mm/h) yielded no significant dif­
ference (P=.6 6 ). Likewise, WBC counts of patients with 
positive scans (m ean± S D , 9 .9 ± 5 .7 X  107L) and pa­
tients with negative scans (m ean±SD , 8 .0 ± 3 .3 X10U/L) 
did not differ significantly (P=.38).
Comparison of the groups with positive and nega­
tive ‘"In-lgG scans showed that a positive scan signifi­
cantly increased the likelihood of reaching a diagnosis: 
in 11 (85%) of 13 patients with a positive scan, a final 
diagnosis was made, compared with only five (45%) of
11 patients with a negative scan (P=.05).
COMMENT
From this study, it can be concluded  that " ‘In-lgG 
scintigraphy is a prom ising technique in the w orkup 
of patients with FUO, as indicated by an overall sensi­
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Table 1. Characteristics of Patients According to Results of Indium In 111 IgG Scans*
Patient/ Fever
Age, y/ ESR, Leukocytes, Duration » Additional
Sex mm/h Clinical Data x  109/L wk Localization of Uptake Final Diagnosis Investigationsf
True-Positive Scans
1/81/F 93 Arthritis of knee, heart 
murmur
11.4 4 Right knee Tuberculous arthritis, 
spondylodiskitis
Puncture, C
2/67/F 132 Lumbar pain
•
8.5 8 Left hip, back Spondylodiskitis, arthritis with 
Group B Streptococcus and 
Propionibacterium acnes
B, C, X
3/23/F 40 Lymphadenopathy, 1 2 7 7 Right lower abdomen Crohn’s disease Colonoscopy
abdominal pain,
arthritis
4/65/M 140 No abdominal 
complaints
26.5 22 Right lower abdomen Ileum metastasis of surgically 
cured lung cancer
X, CT, S, PE
5/63/M 90 No abdominal 
complaints, steroids
5.7 3 Right lower abdomen Abscess with Escherichia coli 
after appendicitis
US, S
6/33/M 70 Recurrent abdominal 7.6 7 Ascending colon Ulcerative colitis X, colonoscopy, PE
pain, no diarrhea
7/48/M 72 Polyarthritis, pleural 
effusion
5.4 8 Both lungs, left hip, knee Nonclassifiable noninfectious 
inflammatory lung disease, 
culture-negative periostitis
Open lung B, CT, 
US, C, B, blood, 
DSA
8/46/M 136 Low thoracic pain, 
pleural effusion
6.6 11 Right lung Pleural empyema and 
spondylitis with 
Staphylococcus aureus
CT, X, B, US, C
9/63/F 20 Polyarthritis, diarrhea 
without blood
10.9 20 No activity in kidney Hydronephrosis in colon 
cancer, E coli in urine
US, X, 
colonoscopy, 
S, PE
False-Positive Scans
10/49/M 50 Fatigue, recurrent fever 
for 5 y
8.1 53 Both hips Aseptic necrosis of hips, no 
cause of fever found
X, Tc bone scan, 
US
11/61/M 120 Nonspecific complaints, 
pain in right hip 
from coxarthrosis, 
spontaneous 
recovery from fever
8.5 7 Right hip No diagnosis S, C
12/25/F 75 Abdominal pain, 
extreme weight loss
3.9 4 Nose, left axilla Systemic lupus erythematosus, 
nonspecific
lymphadenopathy of axilla
B, CT, blood
13/44/F 12 Dyspnea, heart 
murmur, 
spontaneous 
recovery from fever
13.4 23 Ascending colon No diagnosis Blood, C
(continued)
tivity of 82%. The specificity was 69%. These results 
compare favorably with data in literature dealing with 
o ther rad iopharm aceuticals  (Tab le  2). Most sc in ti­
graphic studies in FUO have been performed with gal­
lium citrate  Ga 6 7 2-8 >, 0 >23 and M1In-W BCs . 1M3,24 For 
scin tigraphic  studies w ith Ga 67, sensitivity  ranged 
from 75% to 100% and specificity varied widely, rang­
ing from 38% to 100%. In IMIn-WBC scin tig raphy , 
sensitivity and specificity appeared to be much higher, 
ranging from 90% to 100% and 84% to 86%, respec­
tively. W hen these data are compared, “ ‘In-WBC scin­
tig raphy  seem ed to perform  som ew hat b e tte r  than  
Ga 67 scintigraphy and m ln-lgG scintigraphy. How­
ever, few studies adhere to the criteria for FUO formu­
lated  by P e te rsd o rf  and  B eeson4'711,12; som e even 
include postoperative patients with fever, who often 
have a localized abscess .4,3 Those results canno t be 
extrapolated to those patients with classic FUO, m ak­
ing com parison  of these data som ew hat hazardous. 
Moreover, in m ost o ther studies, only a selection of 
patients with FUO was included .3,5,8,10’11,13,22,23
Knockaert et al8 found in patients with FUO that a 
positive Ga 67 scintigram increased the chances of reach­
ing a final diagnosis; 77% of patients with positive scans 
in contrast to 34% of those with negative scans were given 
a final diagnosis. This is in agreement with our findings 
with the use of m In-IgG: a final diagnosis was made in
10 (77%) of 13 patients with a positive scan and in five 
(45% of 11 patients with a negative scan. In previous ex­
perience with more than 1000 patients studied with 11 'In- 
IgG for a variety of indications ,14,21 this technique had a 
high diagnostic yield, and in comparison with Ga 67 and 
11'In-WBC scintigraphy, it has many advantages. First, 
unlike gallium citrate Ga 67 and technetium Tc99m hexa- 
methylpropyleneamine oxime-labeled WBCs, m In-IgG 
is not secreted in the normal bowel, leading to better de­
tection of abdominal infections or inflammation. In ad­
dition, the radiation burden of gallium citrate Ga 67 is 
higher than that o f 11 ‘ln-IgG, ie, an effective dose equiva­
lent of 27 and 15 mSv, respectively.21,2- In chronic infec­
tion, sensitivity of labeled WBC scintigraphy might be 
limited by the absence of granulocyte influx in this type
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Table 1. Characteristics of Patients According to Results of Indium In 111 IgG Scans* (cont)
Patient/ Fever
Age, y/ ESR, Leukocytes, Duration f Additional
Sex mm/h Clinical Data x  109/L wk Localization of Uptake Final Diagnosis Investigations!
True-Negative Scans
14/25/F 89 Heart murmur; 6.1 6 Equivocal (pelvis) Salmonella sepsis, prompt X, blood, C
Indonesian travel response to antibiotics
15/77/M 112 Cough, diarrhea; 7.4 17 None Hodgkin’s disease and lung S, B, bronchoscopy
artificial heart valves cancer
16/62/M 96 Fatigue; spontaneous 10.0 13- None No diagnosis BM, CT, C, US,
recovery after 4 mo blood
17/52/M 40 Fatigue, slight weight 5.5 12 Equivocal (right lower No diagnosis X, B, CT, B, US, C
loss; pigeon fancier; abdomen)
spontaneous
recovery after 10 mo
18/46/M 140 Myalgia of legs, 5.5 30 Equivocal (lungs) Acute leukemia CT, US, BM,
fatigue, anorexia bone biopsy
19/63/F 112 Fatigue, lumbar pain, 11.1 3 None No diagnosis US, CT, X, B,
transient diarrhea; blood, C
spontaneous
recovery after 4 mo
20/53/F 14 Persistent recurrent 4.6 88 None No diagnosis MR, CT, US, B, X,
fever for > 4  y • blood, C
21/35/M 5 Tick bite; recurrent 4.4 51 None No diagnosis CT, X, B, C, blood,
fever with headache; US
spontaneous
recovery after 1 y
22/27/M 4 Fatigue; spontaneous 7.1 18 Equivocal (colon) No diagnosis US, colonoscopy,
recovery after 10 mo C, blood
False-Negative Scans
23/54/F 93 Heart murmur, kidney 11.7 5 None Infected renal cyst, culture s, C
transplant, renal negative after use of several
cysts antibiotics
24/68/F 71 Scleroderma, heart 14.5 5 None Infected central catheter with CT, X, blood, US, C
murmur, renal failure Staphylococcus epidermidis
*US indicates ultrasound; CT, computed tomography; B, biopsy; C, culture; S. surger)'; MR, magnetic resonance imaging; X, x-ray; BM, bone marrow
aspiration; PE. pathologic examination; DSA, digital subtraction angiography; and Tc, technetium.
t Investigations performed to verify the diagnosis are shown in boldface. For true-positive scans, all additional investigations were performed for verification.
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Figure 1. Patient 2. Abnormal uptake in the left hip and back (arrow) 
caused by spondylodiskitis.
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Figure 2. Patient 3. Abnormal uptake in the right lower abdomen (arrow) 
caused by Crohn’s disease.
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Table 2. Reports on Diagnostic Value of Scintigraphy in Patients With FUO*
Scan Result, No. (%)
I I densmvny, ¿pecmcuy,
Source, y Scan N TP FP TN FN % % Remarks
Nakamura et al,2 1990 Ga 67 49 8 (16) 17(35) •  •  • •  •  • •  •  i •  •  • Abstract
Misaki et al,3 1990 Ga 67 56 23 (41) 10(17) 19(35) 4 (7 ) 85 65 Selected group, abstract
Hilson and Maisey,4 1979 Ga 67 61 47 (77) 3 (5 ) 11(18) 0 (0 ) 100 79 No criteria for FUO,
I also postoperative 
patients
Teates and Hunter,5 1975 Ga 67 42 9 (2 1 ) 5 (1 1 ) 25 (61) 3 (7 ) 75 83 Selected group, no criteria 
for FUO
Suga et al,6 1991 Ga 67 36 17(47) 0 (0 ) 15(42) 4 (1 1 ) 80 100 Retrospective, selected, 
other criteria for FUO
Habibian et al,7 1975 Ga 67 22 12(54) 5 (2 2 ) 3 (1 5 ) 2 (9 ) 86 38 Also postoperative 
patients, no definition 
of FUO
Knockaert et al,0 1989 Ga 67 54 14(26) 8 (1 5 ) 28(51) 4 (7 ) 78 78 Criteria for FUO of 
Petersdorf, selected 
group
Larson et al,23 1982 Ga 67
\
40 10(25) 9 (2 3 ) 18(45) 3 (7 ) 77 67 Criteria for FUO of 
Petersdorf, selected 
group, other definition 
of true positive
Knockaert et al,9 1994 Ga 67 145 42 (29) 40 (28) 54 (37) 9 (6 ) 82 57 Criteria for FUO of 
Petersdorf, selected 
group, retrospective
Schmidt et al,101987 In 111 WBCs 32 7 (2 1 ) 4 (1 3 ) 21 (66) 0(0) 100 84 Criteria for FUO of 
Petersdorf, selected 
group
Syrjala et al,11 1987 In 111 WBCs 68 19(28) 7 (1 0 ) 40 (59) 2 (3 ) 90 85 Other criteria for FUO, 
selected group
McDougall et al,121979 In 111 WBCs 13 3 (2 4 ) 1 (7 ) 9 (6 9 ) 0 (0 ) 100 90 No criteria for FUO 
mentioned, selected 
group
Davies and Garvie,24 1990 In 111 WBCs 28 3 (1 1 ) 5 (1 8 ) 18(64) 2 (7 ) 71 86 Criteria for FUO of 
Petersdorf, selected 
group, retrospective
Becker et al,131993 Tc anti-NCA 34 8 (2 4 ) 1 (3 ) 13(38) 12(35) 40 92 Criteria for FUO of 
Petersdorf, selected 
group, retrospective
Present study In 111 IgG 24 9 (3 8 ) 4 (1 7 ) 9 (3 8 ) 2 (8 ) 82 69 Criteria for FUO of 
Petersdorf, selected 
group, retrospective
*FUO indicates fever of unknown origin; TP, true positive; FP, false positive; TN, true negative; FN, false negative; Ga 67, gallium citrate Ga 67; In 111, 
indium In 111; Tc, technetium; WBCs, white blood cells; and NCA, nonspecific cross-reaching antigen.
of infection .26 In a prospective comparative study in sub­
acute infections, with the use of m In-WBC and 111 In- 
IgG scintigraphy, Oyen et a l1' found a higher diagnostic 
accuracy of m In-IgG scintigraphy.
The need to draw blood and to isolate and label leu­
kocytes makes m In-WBC and l)9mTc-WBC scintigraphy 
more time consuming, complicated, and costly than 111 In- 
lgG scintigraphy. It takes 3 hours to prepare the radio­
pharm aceutical, and not every departm ent of nuclear 
medicine has the facilities to label leukocytes. Of major 
concern are the handling of blood and the possibility of 
administering the cells to the wrong patient.2' There is a 
limitation to the use of all scintigraphic techniques, in­
cluding m In-IgG: lesions in organs with relatively high 
physiologic uptake, eg, liver, heart, spleen, and k id ­
neys, can be missed. Because of these advantages and the 
high diagnostic yield, m ln-IgG scintigraphy may be­
come the first choice in scintigraphic investigations in 
patients with FUO.
Since this study, like all studies on scintigraphic 
m ethods in FUO, is re trospective, the exact role of
m In-IgG scintigraphy in the diagnostic process of pa­
tients with FUO is unknown. Prospective studies are nec­
essary to provide such additional information.
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